Constitutive phosphorylation of AKT is higher among patients with CLL at high risk for RT transformation (i.e., CLL with NOTCH1 mutation, aggressive CLL with TP53 disruption) (53). This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.